BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36126718)

  • 21. Comparison of prognostic impact of lymphovascular invasion in stage IA non-small cell lung cancer after lobectomy versus sublobar resection: A propensity score-matched analysis.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Lung Cancer; 2020 Aug; 146():105-111. PubMed ID: 32526600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 23. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
    Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
    Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
    He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
    Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential efficacy of segmentectomy and wedge resection in sublobar resection compared to lobectomy for solid-dominant stage IA lung cancer: a systematic review and meta-analysis.
    Lin H; Peng Z; Zhou K; Liang L; Cao J; Huang Z; Chen L; Mei J
    Int J Surg; 2024 Feb; 110(2):1159-1171. PubMed ID: 37983767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Mimae T; Saji H; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M
    Ann Surg Oncol; 2021 Nov; 28(12):7219-7227. PubMed ID: 33900499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is tumor diameter a risk factor for occult N1 metastasis in patients with peripheral non-small cell lung cancer which is smaller than 3 cm?
    Sayan M; Celik A; Kankoc A; Akarsu I; Aslan MT; Kurtoglu A; Ahmedova G; Tastepe AI
    Updates Surg; 2023 Dec; 75(8):2335-2342. PubMed ID: 37382803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
    Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and Resected Lymph Node Number During Sublobar Resection for N0 Non-Small Cell Lung Cancer 2 cm or Less.
    Ding H; Wang H; Xu L; Song N; Jiang G
    Ann Thorac Surg; 2019 Jun; 107(6):1647-1655. PubMed ID: 30682353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy.
    Kneuertz PJ; Abdel-Rasoul M; D'Souza DM; Moffatt-Bruce SD; Merritt RE
    Clin Lung Cancer; 2023 May; 24(3):e134-e140. PubMed ID: 36682930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer.
    Jeon HW; Kim YD; Kim KS; Sung SW; Park HJ; Park JK
    World J Surg Oncol; 2014 Jul; 12():215. PubMed ID: 25027055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Spread Through Air Spaces Is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma.
    Vaghjiani RG; Takahashi Y; Eguchi T; Lu S; Kameda K; Tano Z; Dozier J; Tan KS; Jones DR; Travis WD; Adusumilli PS
    J Thorac Oncol; 2020 May; 15(5):792-802. PubMed ID: 32007599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Meldola PF; Toth OAS; Schnorrenberger E; Machado PG; Chiarelli GFC; Kracik JLS; de Carvalho CC; Lôbo MM; Gross JL
    Surg Oncol; 2023 Dec; 51():101995. PubMed ID: 37776757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.